Gerald Li

2.2k total citations
48 papers, 802 citations indexed

About

Gerald Li is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Gerald Li has authored 48 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cancer Research, 23 papers in Pulmonary and Respiratory Medicine and 22 papers in Oncology. Recurrent topics in Gerald Li's work include Cancer Genomics and Diagnostics (28 papers), Lung Cancer Treatments and Mutations (11 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Gerald Li is often cited by papers focused on Cancer Genomics and Diagnostics (28 papers), Lung Cancer Treatments and Mutations (11 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Gerald Li collaborates with scholars based in United States, United Kingdom and Canada. Gerald Li's co-authors include Ryon P. Graf, Geoffrey R. Oxnard, Emily Castellanos, Tamara Snow, Yang Li, Lin Zhou, Mengyue Niu, Ming Yao, Wenyan Kang and Jianjun Liu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Gerald Li

40 papers receiving 795 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerald Li United States	13	312	309	279	224	83	48	802
Claudia Vollbrecht Germany	20	378 1.2×	252 0.8×	295 1.1×	315 1.4×	88 1.1×	45	820
Lisa Golmard France	17	231 0.7×	139 0.4×	218 0.8×	345 1.5×	89 1.1×	51	873
Siew‐Kee Low Japan	21	408 1.3×	486 1.6×	267 1.0×	447 2.0×	80 1.0×	46	1.3k
Jaime Ferrer-Lozano Spain	13	366 1.2×	299 1.0×	187 0.7×	478 2.1×	58 0.7×	27	876
Jamal Benhamida United States	14	245 0.8×	184 0.6×	168 0.6×	303 1.4×	49 0.6×	40	653
A Fornari Italy	11	184 0.6×	334 1.1×	216 0.8×	440 2.0×	61 0.7×	20	857
Aruna Nambirajan India	17	319 1.0×	131 0.4×	303 1.1×	319 1.4×	108 1.3×	78	867
Jui Lan Taiwan	17	226 0.7×	178 0.6×	385 1.4×	233 1.0×	134 1.6×	42	912
Christopher Schroeder Germany	17	308 1.0×	153 0.5×	162 0.6×	249 1.1×	96 1.2×	53	740
Katharina König Germany	14	357 1.1×	246 0.8×	231 0.8×	564 2.5×	121 1.5×	20	1.0k

Countries citing papers authored by Gerald Li

Since Specialization

Citations

This map shows the geographic impact of Gerald Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald Li more than expected).

Fields of papers citing papers by Gerald Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald Li. The network helps show where Gerald Li may publish in the future.

Co-authorship network of co-authors of Gerald Li

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald Li. A scholar is included among the top collaborators of Gerald Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald Li. Gerald Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Graf, Ryon P., Nicolas Sayegh, Gerald Li, et al.. (2025). Association of Homologous Recombination Repair Alterations with Outcomes in Patients with Metastatic Hormone-Sensitive Prostate Cancer. Clinical Cancer Research. 31(19). 4101–4109.

Slomovitz, Brian M., Natalie Danziger, Júlia C.F. Quintanilha, et al.. (2025). Validation of comprehensive genomic profiling for prognostic and potential therapeutic molecular classification of endometrial cancer. International Journal of Gynecological Cancer. 35(10). 102107–102107. 1 indexed citations

Armstrong, Andrew J., William J. Geese, Yu-Han Hung, et al.. (2025). LRP1b Loss Predicts Sensitivity to Immunotherapy in Patients with NSCLC: An Analysis of the Phase III CheckMate-026 Randomized Trial. Clinical Cancer Research. 31(24). 5198–5210.

Richardson, Debra L., Júlia C.F. Quintanilha, Natalie Danziger, et al.. (2024). Effectiveness of PARP Inhibitor Maintenance Therapy in Ovarian Cancer by BRCA1/2 and a Scar-Based HRD Signature in Real-World Practice. Clinical Cancer Research. 30(20). 4644–4653. 5 indexed citations

Bhave, Manali, Júlia C.F. Quintanilha, Ryon P. Graf, et al.. (2024). Abstract PO2-16-05: ESR1 mutations (ESR1mut) in HR(+)HER2(-)patients with metastatic breast cancer (MBC): prevalence along treatment course and predictive value for endocrine therapy (ET) resistance in real-world practice. Cancer Research. 84(9_Supplement). PO2–16.

Bhave, Manali, Júlia C.F. Quintanilha, Hanna Tukachinsky, et al.. (2024). Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(−) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice. Breast Cancer Research and Treatment. 207(3). 599–609. 11 indexed citations

Triner, Daniel, Ryon P. Graf, Russell W. Madison, et al.. (2024). Durable benefit from poly(ADP-ribose) polymerase inhibitors in metastatic prostate cancer in routine practice: biomarker associations and implications for optimal clinical next-generation sequencing testing. ESMO Open. 9(9). 103684–103684. 3 indexed citations

Mack, Philip C., Gerald Li, Katherine T Lofgren, et al.. (2024). Real-World Clinical Performance of a DNA-Based Comprehensive Genomic Profiling Assay for Detecting Targetable Fusions in Nonsquamous NSCLC. The Oncologist. 29(8). e984–e996. 5 indexed citations

Miron, Benjamin, Gerald Li, Júlia C.F. Quintanilha, et al.. (2024). Relationship of tumor fraction in circulating tumor DNA with prognosis in patients with advanced urothelial cancer. SHILAP Revista de lepidopterología. 3. 100004–100004. 5 indexed citations

10.

Quintanilha, Júlia C.F., Ryon P. Graf, Gerald Li, et al.. (2023). Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor Effectiveness. JCO Precision Oncology. 7(7). 26–27. 31 indexed citations

11.

Ellis, Haley, Samuel J. Klempner, Parvathi A. Myer, et al.. (2023). Microsatellite instability (MSI), mismatch repair (MMR), and tumor mutational burden (TMB) as predictive biomarkers for immune checkpoint inhibitor (ICI) effectiveness in real-world patients with metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 41(4_suppl). 46–46. 2 indexed citations

12.

Huang, Richard S.P., David P. Carbone, Gerald Li, et al.. (2023). Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis. Journal for ImmunoTherapy of Cancer. 11(1). e005801–e005801. 20 indexed citations

13.

Quintanilha, Júlia C.F., Ryon P. Graf, Virginia Fisher, et al.. (2023). Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy in Patients With Metastatic Colorectal Cancer With Measures of Microsatellite Instability, Mismatch Repair, or Tumor Mutational Burden. JAMA Network Open. 6(1). e2252244–e2252244. 26 indexed citations

14.

Graf, Ryon P., Kunal Shah, Natalie Danziger, et al.. (2023). Mismatch repair deficiency, next-generation sequencing-based microsatellite instability, and tumor mutational burden as predictive biomarkers for immune checkpoint inhibitor effectiveness in frontline treatment of advanced stage endometrial cancer. International Journal of Gynecological Cancer. 33(4). 504–513. 16 indexed citations

15.

Swami, Umang, Ryon P. Graf, Roberto Nussenzveig, et al.. (2022). SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis–Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer. Clinical Cancer Research. 28(22). 4917–4925. 40 indexed citations

16.

Schwartzberg, Lee S., Gerald Li, Khaled Tolba, et al.. (2022). Complementary Roles for Tissue- and Blood-Based Comprehensive Genomic Profiling for Detection of Actionable Driver Alterations in Advanced NSCLC. JTO Clinical and Research Reports. 3(9). 100386–100386. 18 indexed citations

17.

Huang, Richard S.P., Brennan Decker, Karthikeyan Murugesan, et al.. (2021). Pan-cancer analysis of CD274 (PD-L1) mutations in 314,631 patient samples and subset correlation with PD-L1 protein expression. Journal for ImmunoTherapy of Cancer. 9(6). e002558–e002558. 8 indexed citations

18.

Niu, Mengyue, Yang Li, Gerald Li, et al.. (2020). A longitudinal study on α‐synuclein in plasma neuronal exosomes as a biomarker for Parkinson’s disease development and progression. European Journal of Neurology. 27(6). 967–974. 131 indexed citations

19.

Bankhead, Peter, José A. Fernández, Darragh G. McArt, et al.. (2017). Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer. Laboratory Investigation. 98(1). 15–26. 77 indexed citations

20.

Li, Gerald, et al.. (2012). Technologies supporting analytical cytology: clinical, research and drug discovery applications. Journal of Biophotonics. 5(4). 313–326. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact